Factors influencing women's decision to participate or not in a surgical randomised controlled trial for surgical treatment of female stress urinary incontinence by Mostafa, Alyaa et al.
Hindawi Publishing Corporation
BioMed Research International
Volume 2013, Article ID 139813, 8 pages
http://dx.doi.org/10.1155/2013/139813
Research Article
Factors Influencing Women’s Decision to Participate or
Not in a Surgical Randomised Controlled Trial for Surgical
Treatment of Female Stress Urinary Incontinence
Alyaa Mostafa,1 James N’Dow,2 and Mohamed Abdel-Fattah1
1 Division of Applied Health Sciences, University of Aberdeen, 2nd Floor, Aberdeen Maternity Hospital,
Foresterhill, Aberdeen AB25 2ZD, UK
2Division of Applied Health Sciences, University of Aberdeen, Academic Urology Unit, 2nd Floor Health Sciences Building,
Foresterhill, Aberdeen AB25 2ZD, UK
Correspondence should be addressed to Mohamed Abdel-Fattah; m.abdelfattah@abdn.ac.uk
Received 29 April 2013; Accepted 29 July 2013
Academic Editor: Charnita M. Zeigler-Johnson
Copyright © 2013 Alyaa Mostafa et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The study aims to explore the potentially influential factors affecting women’s decision to accept/decline participation in surgical
randomised trial using a novel acceptance/refusal questionnaire (ARQ). All women who were eligible to participate in SIMS-RCT
were asked to complete the relevant section (acceptance/refusal) of the ARQ. Women reported its degree of relevance for their
decision on a six-point Likert scale (0 = highly irrelevant, 5 = highly relevant). 135 (98%) and 31 (70%) women completed the
acceptance and refusal sections of the ARQ, respectively. The most influencing factor in women’s acceptance was the anticipation
of “potential personal benefit”; percentage of relevance (POR) was 91.9%, followed by interest in helping others by “supporting
innovative medical research”; POR was 87.7%. Most influencing factor in refusal for participation was “do not have time for follow-
up”; PORwas 56.8%, followed by “do not like the concept of randomisation”; PORwas 54.4%. In conclusion, this study identifies the
most influential factors relevant to women decision-making whether or not to participate in RCTs assessing surgical interventions
for female stress urinary incontinence (SUI). A number of factors leading to refusal of participation are potentially correctable
leading to better recruitment rates in future RCTs.
1. Introduction
Randomised controlled trials (RCTs) are considered the gold
standard for the evaluation of the effectiveness and safety of
healthcare interventions and are widely accepted as the most
powerful research method in evaluating health technologies,
principally because they minimise selection bias [1]. RCTs
depend entirely on volunteering participants, and therefore
one of the main challenges facing RCTs is adequate recruit-
ment [2, 3]. Unfortunately, large number of clinical trials fail
to achieve their recruitment target [4, 5], leading to poor sta-
tistical power and often inconclusive results [6, 7]. A survey
[8] of 41 multicentre RCTs by the National Institute of Health
in North America reported that 14/41 trials (34%) recruited
less than 75% of their recruitment goal. Similarly, out of 114
RCTs in the United Kingdom (UK) between 1994 and 2002,
only 31% of trials achieved their anticipated recruitment
target within the initial recruitment projection time frame,
and 53% required an extension for recruitment period [9].
Extension of the initially planned recruitment period can lead
to recruitment fatigue andwill have significant impact on trial
funding and on the work load of the whole trial team [10].
A number of studies have identified number of barriers
for participating in clinical nonsurgical RCTs such as patients’
strong preference for or against certain treatment [11, 12],
trial demands, and time constraints such as, additional time/
expenses required for further follow-up commitments [13–
15].
Surgical randomised trials fundamentally differ due to the
invasiveness of the interventions, the patients’ anxiety on
potential surgical morbidity, and/or lack of efficacy data that
will inevitably characterise the study arm/new intervention.
In addition, the motivational differences of patients allocated
to the study arm/new intervention versus the standard
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treatment may have an important influence in participants’
retention within surgical RCTs particularly when blinding
patients is not possible [16]. Some patients accept postopera-
tive pain and certain postoperative complication as “part and
parcel” of the surgical package, while their main emphasis
would be on the effectiveness of the procedure; others will
have minimal tolerance to postoperative complications espe-
cially withminimal invasive procedures. Hence, motivational
differences can be considered as one of the driving leads for
patient’s choice to participate or not in surgical RCTs.
There is a paucity of data in the current literature on the
potential patient’s barriers/incentives for participation in
surgical RCTs; the concept of randomised allocation for
treatment [17], desire, or willingness to help others [18],
potential for individual benefit [19, 20], and the understand-
ing of trial details and randomisation process [17, 21], issues
related to the surgery such as indication of surgery, type
of interventions, and surgeons experience [14, 22–24] were
potentially influential in patients’ decision to participate in
surgical RCTs. Interestingly, the little existing evidence is
mostly derived from qualitative studies, and therefore quite
small cohorts were assessed.
In this study, we aim to explore the influential factors
affecting women’s decision on recruitment and participation
in amulticentre surgical RCT comparing a new surgical inter-
vention versus the standard surgical treatment of female
stress urinary incontinence (SUI).
2. Materials and Methods
The SIMS-Trial is a multicentre RCT comparing a relatively
new procedure “Single-incision mini slings (SIMS-Ajust)”
versus a standard midurethral sling (SMUS-TVT-O), in
management of female SUI [25]. Women were recruited in 6
UK centres, in the period betweenOctober 2009 andOctober
2010, and the 1-year outcomes have been published [26].
During the pretrial counselling, women were informed
that the existing evidence for SIMS was quite limited and
showed better tolerability to be done under local anaesthesia
(LA) and lower incidence of post-operative pain, shorter hos-
pital stay, quicker recovery, and earlier resumption of day-to-
day activities and return to work [27]. However, women were
fully informed of the lack of long-term outcome data for the
SIMS and that SMUS in the control arm (TVT-O) was con-
sidered as the standard treatment and is currently the most
common primary continence procedure worldwide [28].
Women were also informed that TVT-O is exclusively per-
formed under general anaesthesia (GA) anaesthetic [29] and
has shown to have objective and patient-reported cure rates of
73–82% and 70–74%with up to 5 years or followup [30]; how-
ever, can be associated with a relatively high incidence of
short-term postoperative groin/thigh pain [31].
The protocol for SIMS-RCT was published on the public
domain (www.clinicaltrials.gov) in October 2009 and was
approved by the North of Scotland Research Ethics Commit-
tee who approved the administration of a purpose-designed
“acceptance/refusal questionnaire (ARQ)” to all eligible
women. In summary, women were included if they had SUI
and had failed or declined pelvic floor muscle training
(PFMT), which is the first line of conservative management
of SUI prior to the surgical intervention [32]. Women with
pelvic organ prolapse (≥POP-Q Stage 2), previous continence
surgery, concomitant surgery, or neurological conditions
were excluded. The study was adequately powered (95%
power) to detect a clinically significant 25% treatment effect
(1-point difference on visual analogue scale (VAS), and used a
computer-generated randomisation with adequate allocation
concealment. All eligible women were invited to participate
and received a preoperative package including patient infor-
mation sheet with details about the type of procedures and
study details. In addition, the preoperative pack included
symptom severity and quality of life (QoL) assessment ques-
tionnaires and the ARQ.
This study for evaluating the factors influencing women’s
decision to participate or not in surgical RCTs was embedded
in the SIMS-RCT.Womenwere informed that completing the
ARQ was completely voluntary and that their responses will
be handled confidentially and anonymous and will not affect
their furthermanagement or care. Participants completed the
ARQ in their own privacy either during their hospital clinic
or at their home when they received their preoperative packs.
Womenwere able to clarify their understanding of any part of
the questionnaire with their consultant or the research team.
2.1. Acceptance/Refusal Questionnaire (ARQ). The ARQ was
developed based on the best available literature; however,
most of the literature is derived from nonsurgical RCTs [19,
33, 34]. Consumer’s representatives, patient support group
in the Scottish Pelvic Floor Network, were involved in the
design of this questionnaire from its early stages; this included
a number of modifications to ensure a layman language.
Moreover, advice from urogynecology consultants and aca-
demics with experience in surgical RCTswas thought (see the
appendix).
The ARQ has 2 sections, acceptance and refusal. We have
grouped the concepts into 5 key concept groups relating to:
(a) views about the trial process and procedures, (b) the possi-
ble self-benefits, (c) possible benefit/help to others (known as
altruism) (d) personal circumstances during the trial period,
and (e) views regarding the interventions compared in the
trial. Similar questionswere asked in differentwayswithin the
questionnaire to assess consistency of responses. For each fac-
tor, womenwere asked to rank its degree of relevance for their
decision-making whether to participate or not, on a 6-point
Likert scale (ranging from 0 = highly irrelevant to 5 = highly
relevant). To determine the content validity of the question-
naire, it ended with an open-ended question for patients
to add any other possible influential factors that were not
included in the closed items of the questionnaire. The ARQ
was then piloted among the first 30 eligible women and
was answered by 27; the results showed minimal missing
data and no incidents of incomprehensible questions within
the acceptance or refusal sections. Furthermore, no other
relevant influencing factors were identified from the open-
ended question.
A scoring system was developed for the ARQ. The total
score for each factor was calculated as the number of respon-
dents for each Likert value (𝑛) multiplied by the particular
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likert value (𝐿); that is, 𝐿 = 0, 1, 2, . . . 5, such that the final
total score for each factor = 𝑛 ∗ 0 + 𝑛 ∗ 1 + 𝑛 ∗ 2 + 𝑛 ∗ 3 +
𝑛 ∗ 4 + 𝑛 ∗ 5. For both acceptance and refusal, the minimum
score is zero. However, the maximum score varies according
to the number of respondents (𝑛); for the acceptance section
of the ARQ, there were 135 respondents, providing a potential
total score maximum of 675 (135 ∗ 5). In the case of refusal,
there were 31 respondents, giving a maximum possible total
score of 155 (31 ∗ 5). To allow comparison across factors
and in-between studies, we calculated the percentage of
relevance (POR) for each factor = actual total score for each
factor/divided by the potential maximum score, for exam-
ple, the POR for “the potential personal benefit” = total
score/maximum score = 620/675 that is 91.8%.
Data collected were observational, and descriptive anal-
ysis was undertaken and presented as percentages for each
concept group. Statistical analysis was performed under
statistician supervision, using SPSS 18.0 (Chicago, Il, USA).
3. Results
In the SIMS RCT, 274 patients were referred for surgical
management of SUI in all participating centres, and 181
patients were eligible to participate in this trial. 137 patients
agreed to participate in the RCT compared to 44 patients who
refused to participate. The responses rate was excellent; 135/
137 (98.5%) patients completed the acceptance section of the
ARQ, and 2/137 (1.5%) patients had >2 missing answers
(Figure 1). 31/44 (70%) patients completed the refusal section
of the ARQ, 8/44 (18.6%) had >2 missing answers, and 5/44
(11.4%) patients refused to complete the questionnaire with-
out reporting any reasons.
Baseline characteristics were comparable for women who
have completed either section of the ARQ (Table 1).
135/137 (98.5%) of participating women fully completed
the acceptance section in the ARQ. 74% (𝑛 = 100) rated
“potential personal benefit” as highly influential (i.e., rank 5
on the likert scale) in their decision to participate. This was
followed by “possible benefit to others (known as altruism)”
and “willingness to support innovative medical research”
with 67% giving it top rank (5 on likert scale) (Figure 2(a)).
Figure 2(b) summarises the comparison of all factors affect-
ing women’s decision to participate in this RCT by the
percentage of relevance (POR). Highest POR was for the
“potential personal benefit” with a total score of 620/675
(91.8%), followed by “possible benefit to others (known as
altruism)” with a total score of 592/675 (87.7%).
Potential factors listed in the refusal section of the ARQ
were all closely relevant to women’s decision to decline par-
ticipation in this RCT. 32.5% women ranked “not interested
in research” and “do not like the concept of randomisation”
as the highly relevant (rank 5 on the likert scale). 29% of
nonparticipatingwomen reported that they “do not have time
for follow-up process” or are generally “not interested in
research,” as the most influential factors in their decision-
making (Figure 3(a)). Figure 3(b) summarises the compari-
son of all factors affecting women’s decision to decline partic-
ipation in this RCT by the percentage of relevance (POR).
Six women completed the open-ended question at the
end of the ARQ: 2 participants and 4 in the declining group.
Table 1: Baseline characteristics.
Acceptance pt.
𝑛 = 135
Refused pt.
𝑛 = 31
𝑃 value
Age: 𝑛 (%)
≤25 0 (0%) 0 (0%)
0.34226–44 46 (34.1%) 16 (51.6 %)
45–64 73 (54.1%) 12 (38.7 %)
≥65 16 (11.8%) 3 (9.7 %)
Parity: 𝑛 (%)
0 6 (4.4%) 5 (16.1%)
0.120
1 25 (18.5%) 3 (9.7%)
2 63 (46.7%) 16 (51.6%)
3 28 (20.7%) 4 (12.9%)
≥4 13 (9.6%) 3 (9.7%)
Work status: 𝑛 (%)
Working 96 (71.1%) 26 (83.8%)
0.405Not working 28 (20.7%) 3 (9.7%)
Retired 8 (5.9%) 2 (6.5%)
Missing 3 (2.2%) 0 (0%)
Women added number of reasons that affected their decision-
making: “I would like to improve the level of provided health-
care for future patients”; “I am really interested to go to work
as quickly as the post-operative recovery will allow.” One
woman in the declining group added that she is “so busy and
have many family and social issues, so cannot commit to any
further follow-up”; further 3women expressed guilt about not
being able to help with research but cannot overcome their
preference to have the standard procedure (TVT-O).
4. Discussion
Surgical RCTs are expensive to set-up and run, usually requir-
ing significant resources, manpower, and financial invest-
ment and therefore every step should be taken to optimise
their success. There is a general understanding in the com-
munity that patients’ recruitment is an integral factor for the
success ofmedical research, yet in practice, fewer patients vol-
unteer to participate in surgical RCTs [35].
SIMS RCT is a comparison between two surgical inter-
ventions in themanagement of womenwith SUI. It is a typical
surgical RCT where there is uncertainty regarding the long-
term surgical outcome in the study group while there are
potential short-term personal benefits such as feasibility to be
done under LA, lower postoperative pain and earlier return
to normal activities and work. Hence, the SIMS-RCT repre-
sented an ideal opportunity to explore the influential reasons
in women’s decision-making whether or not to participate in
surgical RCTs.
The recruitment rate was reasonable at 75.7% of eligible
women and is comparable with other RCTs in this field. All
women were well informed that the completion of the ARQ
is entirely voluntary; the response rate for the acceptance
group was high (98.5%), while it was 70% for the refusal
group. The most influential reasons in women’s decision to
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Assessed for eligibility 
Completed all questions for the refusal Completed all questions for the acceptance 
(n = 274)
Not meeting inclusion criteria (n = 93)
Had concomitant surgery (n = 53)
Had previous incontinence surgery (n = 23)
Had mixed urinary incontinence (n = 14)
Had multiple neurological disorders (n = 3)
Eligible for recruitment (n = 181)
Accepted to participate and randomised
(n = 137)
Refused to participate (n = 44)
Had >2 missing answers
(n = 2)
Had >2 missing answers (n = 10)
Did not complete ARQ (n = 3)
section of the ARQ (n = 135) section of ARQ (n = 31)
Analysed: (n = 135) Analysed: (n = 31)
Figure 1: SIMS-Ajust study and ARQ; flow chart of recruited patients.
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Figure 2: (a) Reasons for accepting to participate, (b) percentage of relevance (POR) for accepting reasons.
participate were their interest in potential personal benefits
within the new intervention and altruism.These findings are
in agreement with previous studies exploring the potential
influencing factors for participation in clinical nonsurgical
RCTs [18–20].
Altruism was previously rated as the main motivation
for participation in clinical RCTs [18, 36]; however, recent
evidence has been more cautious about the role of altruism.
It has been suggested that patients can be initially motivated
towards participating in a trial based on their willingness to
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Figure 3: (a) Reasons for accepting to participate, (b) percentage of relevance (POR) for refusal reasons.
help others or to help research in general; however, this would
be heavily influenced by whether there is a potential personal
benefit in participating in that particular RCT; this is known
as “conditional altruism” [37]. There is no evidence in the
literature to compare the percentage of personal benefits and
helping others as a motivation to participate in a clinical trial.
“Good explanation of the study aim, design, and the
followup plan” was highly ranked by women in our study as
an influential factor in their acceptance decision.This is really
a common sense finding and previous literature showed that
people’s decisions about whether or not to take part in trials
depend on their level of understanding of the study aims and
steps. Bevan et al. and Bergmann et al. [38, 39] have shown
that the lack of study information, especially the clarity of the
aim and methods, is a well recognised reason for a patients
decision to decline participation in nonsurgical RCTs. Other
studies have shown that RCTs with perceived additional
demands for inclusion or followup can suffer from difficulties
in recruitment and retention [14, 33].
Patient preference to a particular surgery has been previ-
ously cited as one of the main barriers for recruitment and
postrandomisation retention in surgical RCTs [40]. Plaiser
et al. and McCulloch et al. [14, 41] reported significant
number of participants withdrawing after randomisation if
they receive the more invasive procedure. In our study, the
surgical difference between both study armswas perceived by
women to be minimal hence was not shown to significantly
influence women’s decision-making.
There are several factors for eligible women refusing to
participate inRCTs. In our study, themost influential factor in
women’s decision to decline participation was their concerns
regarding additional follow-up demands and its associated
inconvenience, expenses, and time. Ross et al. [33] have pre-
viously shown similar results where additional trial demands
and time constraints were seen as barriers for recruitment
in nonsurgical RCTs. A number of studies [13, 14] reported
patient’s concerns regarding potential discomfort within the
follow-up process due to potential repeated examination as a
significant barrier for participating in RCTs. This is a poten-
tially correctable factor and was not a concern in our RCT
as we emphasised on patient-reported outcomes and avoided
any postoperative invasive tests or internal examinations that
will not be required in routine clinical practice.
The concept of “random” allocation for treatment and
receiving treatment on the bases of chance was a highly rel-
evant reason in women’s decision to decline participation in
our study; similar findings were previously reported in non-
surgical RCTs [17]. This highlights that the rational for ran-
domisation and the understanding of the process involved
appears to be poorly understood by many participants [21].
Once more, this is a correctable factor and requires more
input in the patient information sheet to provide more expla-
nation to the patient and researchers dedicating more time
and explanation in the pretrial counselling.
Previous studies have shown that the lack of efficacy
data on the treatment in the study arm and the “fear of the
unknown” associated with new interventions are potential
factors for refusing to participate in clinical trials [14, 42].
Similarly, we found the lack of long-term efficacy data on
SIMS-Ajust (study arm) was one of the influential reasons in
women’s decision to decline participation.
One of the study strength is presenting the new assess-
ment tool “ARQ” which proved to be useful in assessing the
potentially influential factors in the women’s decision-mak-
ing process.TheARQwas structured to target RCTs involving
surgical interventions for improvement of QoL rather than
life-threatening or cancerous conditions. As the women com-
pleting the ARQ were recruited from several centres within
Scotland (both urban and rural), it is fair to generalise the
results for the wider population.The questionnaire was com-
pleted in women’s privacy, and therefore their responses were
not influenced by external factors and specifically the doctor-
patient relationship. ARQ can be analysed as POR for each
factor to allow comparison across factors and in-between
studies, despite variation in the number of participants.
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A main strength of the ARQ is the public engagement in
the design of the questionnaire alongside the literature evi-
dence and expert advice. In summary, the ARQ findings rep-
resent a good base for further research—into the validation of
this promising tool. A potential limitation in our study is the
relatively small number of women completing the refusal sec-
tion of the ARQ as only 25% of eligible women declined par-
ticipation in the SIMS RCT.
4.1. Study Implications. Better understanding of the influen-
tial factors in potential participants’ decision-making is cru-
cial if we are to improve our recruitment and retention rates
in surgical RCTs. Our study has identified a number of rele-
vant factors which can be modified or improved to enhance
recruitment in surgical RCTs in the field of female UI. Rela-
tively simple and cheap measures such as providing complete
and thorough information on the RCTs’ aims and methods
are needed.This needs to be done using easily understandable
language, possibly using coloured illustrations, figures and
possibly the use of add-back audiovisual technology/web-
links. Better patient understanding of the randomisation
process and its significance to the robustness of the results is
crucial if we are to stand a chance in improving recruitment
and retention. Lessons learned from this study will be impor-
tant in designing large definitive interventional RCTs in the
field female UI.
5. Conclusion
The decision to participate or not to participate in surgical
trials is likely to be multifactorial and would be better
understood by a balance between altruism and considera-
tions for potential personal benefit known as “conditional
altruism.” Additional demands on the patients’ time, lack of
understanding the importance of the randomisation process
and clarity of the study details are the most influential,
and potentially correctable factors in women’s decision to
decline participating in surgical RCT.The results of this study
provide urogynaecology and surgical researchers with better
understanding of the patient’s decision-making process when
considering participation in RCTs.This should allow them to
improve study designs/protocols/patient information/follow-
up commitments to allow maximum recruitment.
Appendix
Acceptance/Refusal Questionnaire (ARQ)
Dear Patient
If you have chosen to participate in the study, please
complete Section A and sign the consent form if not
already done. Otherwise please complete Section B.
Section A. Please look at the reasons below and grade the
degree of relevance for each factor to your decision to par-
ticipate in this RCT (“zero” is not relevant and “5” is highly
relevant”)
(i) I see no major differences between the 2 procedures:
0 1 2 3 4 5
(ii) The follow-up plan is appropriate and convenient:
0 1 2 3 4 5
(iii) I received good study explanation:
0 1 2 3 4 5
(iv) I would like to support innovative medical research:
0 1 2 3 4 5
(v) I am interested in a potential personal benefit:
0 1 2 3 4 5
(vi) Other reasons: Please expand: . . . . . . . . . . . . . . . . . .
Section B. If you have chosen not to participate in the study
it would be very helpful if you could let us know the most
important reason(s) for your decision by completing Section
B.However youdon’t have to state any reasons and you should
be sure that it won’t affect your medical care.
I have declined to participate or withdrawn from this study
because (Please look at the reasons below and grade their
relevance to you where “zero” is not relevant and “5” is highly
relevant”)
(i) I am not interested in research:
0 1 2 3 4 5
(ii) I am not well informed about study:
0 1 2 3 4 5
(iii) There is a lack of long-term results for the new
procedure:
0 1 2 3 4 5
(iv) I do not like the concept of randomisation in this
study:
0 1 2 3 4 5
(v) I do not have time for the follow-up plan:
0 1 2 3 4 5
(vi) Other reasons: Please expand: . . . . . . . . . . . . . . . . . .
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